| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 331763-73-6 | (R)-3-Amino-4-(4-bromophenyl)butyric acid hydrochloride;(betaR)-beta-Amino-4-bromobenzenebutanoic acid hydrochloride | C10H12BrNO2.HCl |
| 331763-75-8 | Boc-(R)-3-Amino-4-(4-bromophenyl)butyric acid;(betaR)-4-Bromo-beta-[[(tert-butoxy)carbonyl]amino]benzenebutanoic acid | C15H20BrNO4 |
| 331763-77-0 | (S)-3-Amino-4-(4-nitrophenyl)butyric acid;(betaS)-beta-Amino-4-nitrobenzenebutanoic acid hydrochloride | C10H12N2O4.HCl |
| 331763-78-1 | (R)-3-Amino-4-(4-nitrophenyl)butyric acid hydrochloride;(betaR)-beta-Amino-4-nitrobenzenebutanoic acid hydrochloride | C10H12N2O4.HCl |
| 331771-20-1 | ZM-447439;N-[4-[[6-Methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]amino]phenyl]benzamide | C29H31N5O4 |
| 331818-28-1 | 5-[(4-Nitrophenoxy)methyl]-1,3,4-thiadiazol-2-amine | C9H8N4O3S |
| 331834-13-0 | Benzo[b]furan-5-boronic acid;Benzofuran-5-boronic acid | C8H7BO3 |
| 331862-41-0 | [2-Methoxy-4-[(4-oxo-2-thioxo-5-thiazolidinylidene)methyl]phenoxy]acetic acid | C13H11NO5S2 |
| 331943-04-5 | Celecoxib EP Impurity B;4-[3-(4-methylphenyl)-5-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide | C17H14F3N3O2S |
| 331978-27-9 | 1-(Pyridin-3-ylmethyl)piperidine-3-methanol | C12H18N2O |
| 331994-00-4 | (2R)-2-methylazepane;hydrochloride | C7H16ClN |
| 332012-40-5 | Telatinib;Bay 57-9352; 4-[[[4-[(4-Chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl]oxy]methyl]-N-methyl-2-pyridinecarboxamide | C20H16ClN5O3 |
| 332026-86-5 | 4-(1H-Benzimidazol-2-yl)-1,2,5-oxadiazol-3-amine | C9H7N5O |
| 332062-01-8 | (S)-3-Amino-4,4-diphenylbutyric acid hydrochloride;(betaS)-beta-Amino-gamma-phenylbenzenebutanoic acid hydrochloride | C16H17NO2.HCl |
| 332062-03-0 | (R)-3-Amino-4,4-diphenylbutyric acid;(betaR)-beta-Amino-gamma-phenylbenzenebutanoic acid hydrochloride | C16H17NO2.HCl |
| 332062-06-3 | Boc-(R)-3-Amino-4,4-diphenylbutyric acid;(betaR)-beta-[[(tert-Butoxy)carbonyl]amino]-gamma-phenylbenzenebutanoic acid | C21H25NO4 |
| 332064-73-0 | (3R)-3-[[(tert-Butoxy)carbonyl]amino]-6-phenyl-5-hexenoic acid | C17H23NO4 |
| 332064-85-4 | (3S)-3-Amino-5-hexynoic acid hydrochloride | C6H9NO2.HCl |
| 332064-87-6 | (R)-3-Amino-5-hexynoic acid hydrochloride | C6H9NO2.HCl |
| 332064-91-2 | (3R)-3-[[(tert-Butoxy)carbonyl]amino]-5-hexynoic acid | C11H17NO4 |
| 332064-94-5 | (3R)-3-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-5-hexynoic acid | C21H19NO4 |
| 332099-01-1 | 2-Chloro-6H-thieno[2,3-b]pyrrole-5-carboxylic acid ethyl ester | C9H8ClNO2S |
| 332099-11-3 | 2-Bromo-4H-furo[3,2-b]pyrrole-5-carboxylic acid | C7H4BrNO3 |
| 332099-36-2 | 3-Bromo-4H-thieno[3,2-b]pyrrole-5-carboxylic acid | C7H4BrNO2S |
| 332117-28-9 | 1,2,3,6-Tetrahydro-1,3-dimethyl-N-[4-(1-methylpropyl)phenyl]-2,6-dioxo-7H-purine-7-acetamide;Chembridge 5861528 | C19H23N5O3 |
| 332133-92-3 | 4-(Tributylstannyl)pyrimidine;Tributyl(pyrimidin-4-yl)stannane | C16H30N2Sn |
| 332136-76-2 | 2-Perfluorodecylethyl bromide;12-Bromo-1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10-heneicosafluorododecane | C12H4BrF21 |
| 332154-57-1 | 4-Chlorocarbonylphenylboronic acid | C7H6BClO3 |
| 332154-58-2 | 3-(Chlorocarbonylphenyl)boronic anhydride | C7H5BClO2 |
| 332173-87-2 | N-[(8-Hydroxy-7-quinolinyl)phenylmethyl]-2-methylpropanamide | C20H20N2O2 |
| 332186-76-2 | (alphaS)-4-Hydroxy-alpha,2,6-trimethylbenzenepropanoic acid | C12H16O3 |
| 332187-56-1 | 3,3-Dimethoxycyclobutanecarboxylic acid | C7H12O4 |
| 332187-61-8 | 6-Chloro-1,2-dihydro-2-oxospiro[4H-3,1-benzoxazine-4,4'-piperidine]-1'-carboxylic acid tert-butyl ester | C17H21ClN2O4 |
| 332366-57-1 | 6-Bromo-4(1H)-quinolinone;6-Bromo-1H-quinolin-4-one; 6-Bromo-4-quinolone | C9H6BrNO |
| 332371-82-1 | (4E,6E)-1,7-Bis(4-hydroxyphenyl)-4,6-heptadien-3-one | C19H18O3 |
| 332411-18-4 | 4-[Bis(3-methylphenyl)aminobenzaldehyde;4-(Di-m-tolylamino)benzaldehyde | C21H19NO |
| 332883-10-0 | 5,6,7,8-Tetrahydro-1,8-naphthyridine-2-methanamine | C9H13N3 |
| 332884-13-6 | 5,6,7,8-Tetrahydro-1,8-naphthyridin-2-ethylamine | C10H15N3 |
| 332884-21-6 | 5,6,7,8-Tetrahydro-1,8-naphthyridin-2-butyric acid | C12H16N2O2 |
| 332884-35-2 | 6-Amino-2-pyridinecarboxaldehyde | C6H6N2O |
| 332927-03-4 | 9-Acridinecarboxylic acid hydrate | C14H9NO2.x(H2O) |
| 332941-25-0 | 3,6,9,12,15,18,21-Heptaoxatricosane-1,23-diamine | C16H36N2O7 |
| 332941-39-6 | [2-[2-[2-[2-[[(2,5-Dioxo-1-pyrrolidinyl)oxy]carbonyl]-5-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenoxy]ethoxy]ethoxy]ethyl]-carbamic acid 1,1-dimethylethyl ester | C24H29F3N4O9 |
| 333326-97-9 | N-[4-[(3,5-Diamino-4H-pyrazol-4-ylidene)hydrazino]phenyl]acetamide | C11H13N7O |
| 333333-34-9 | 1,3-Dihydro-1-oxo-5-isobenzofurancarboxaldehyde;5-Formylphthalide | C9H6O3 |
| 333335-93-6 | N-Benzoyl-2'-O-(2-methoxyethyl)adenosine;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]purin-6-yl]benzamide | C20H23N5O6 |
| 333338-18-4 | 4-Nitrophenyl phosphate disodium salt hexahydrate | C6H4NNa2O6P.6(H2O) |
| 333352-59-3 | NBD-557;N-(4-Bromophenyl)-N'-(2,2,6,6-tetramethylpiperidin-4-yl)oxalamide | C17H24BrN3O2 |
| 333353-44-9 | NBD 556;N-(4-Chlorophenyl)-N'-(2,2,6,6-tetramethylpiperidin-4-yl)oxalamide | C17H24ClN3O2 |
| 333361-85-6 | Trianthenol;(4E)-5,9,13,17-Tetramethyl-2-(5,9,13-trimethyl-1-methylenetetradecyl)-4-octadecen-1-ol | C40H78O |